Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 8 Week, Randomized, Double-Blind, Parallel Group, Multicenter Trial Comparing the Efficacy and Safety of Oral IPL512,602 to Placebo in Subjects With Moderate to Severe Persistent Asthma Inadequately Controlled on Inhaled Corticosteroids

NCT00330070 is registered in ClinicalTrials.gov with Inflazyme Pharmaceuticals Ltd as lead sponsor.

NCT NCT00330070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 8 Week, Randomized, Double-Blind, Parallel Group, Multicenter Trial Comparing the Efficacy and Safety of Oral IPL512,602 to Placebo in Subjects With Moderate to Severe Persistent Asthma Inadequately Controlled on Inhaled Corticosteroids
Lead sponsor
Inflazyme Pharmaceuticals Ltd
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
January 31, 2007
Enrollment
200
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

asthma